Provenance du réseau au premier degré de Robert H. Rosen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 26 | |
| Public Company | Biotechnology | 26 | |
| Extinct | Medical Specialties | 12 | |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Sanofi-Synthelabo, Inc.
5
| Extinct | Pharmaceuticals: Major | 5 |
| Extinct | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Robert H. Rosen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Sales & Marketing General Counsel Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel General Counsel | |
| CELGENE | Biotechnology | Human Resources Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Executive Officer Corporate Officer/Principal General Counsel | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing Corporate Officer/Principal | |
| Rochester Christian University | College/University | Masters Business Admin Undergraduate Degree | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ANAPTYSBIO, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Director of Finance/CFO | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Sales & Marketing Chief Executive Officer Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KINTARA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Masters Business Admin Corporate Officer/Principal Corporate Officer/Principal | |
| Boston University | College/University | Undergraduate Degree Masters Business Admin | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Executive Officer | |
| San Diego State University | College/University | Masters Business Admin Masters Business Admin | |
| Brigham Young University | College/University | Undergraduate Degree Graduate Degree | |
| Colgate University | College/University | Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| Oregon State University | College/University | Undergraduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Florida | College/University | Undergraduate Degree Undergraduate Degree | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Chief Operating Officer Founder Director/Board Member General Counsel Chief Tech/Sci/R&D Officer Director/Board Member | |
Real Chemistry, Inc.
 Real Chemistry, Inc. Data Processing ServicesTechnology Services Real Chemistry, Inc. is an end-to-end healthcare experience group that leverages advanced AI-powered insights, diverse expertise, and customer-centric ideas to transform the healthcare industry. Real Chemistry is based in New York, NY and has subsidiaries in Canada, United Kingdom, and United States. The company helps healthcare professionals better understand, reach, and engage patients, while creating healthcare experiences that span diagnosis to adherence. The company was founded in 2001 by Jim Weiss. Shankar Narayanan has been the CEO of the company since 2022. | Data Processing Services | Director/Board Member Consultant / Advisor | |
Dendreon Pharmaceuticals, Inc.
 Dendreon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Dendreon Pharmaceuticals, Inc. discovers, develops and commercializes novel products for the treatment of cancer. The company is headquartered in Olympia, WA. | Medical Specialties | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| REVELATION BIOSCIENCES, INC. | Biotechnology | Chairman Director of Finance/CFO Chief Executive Officer Director/Board Member Director/Board Member Investor Relations Contact Corporate Officer/Principal | |
| ODONATE, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Director of Finance/CFO | |
Revelation Biosciences Sub, Inc.
 Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Part of Revelation Biosciences, Inc., Revelation Biosciences Sub, Inc. develops medical devices. The company is based in San Diego, CA. James M. Rolke has been the CEO of the company since 2020. Revelation Biosciences Sub was acquired by Petra Acquisition, Inc. on January 11, 2022 for $87.36 million. | Medical Specialties | Chairman Chief Executive Officer Director/Board Member | |
| INHIBRX, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 46 |
| Allemagne | 3 |
| Israël | 2 |
| France | 2 |
Sectorielle
| Health Technology | 34 |
| Consumer Services | 15 |
| Commercial Services | 2 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 264 |
| Corporate Officer/Principal | 216 |
| Independent Dir/Board Member | 98 |
| Chief Tech/Sci/R&D Officer | 75 |
| Undergraduate Degree | 73 |
Relations les plus connectées
| Insiders | |
|---|---|
| John Johnson | 40 |
| Dennis Fenton | 28 |
| John E. Osborn | 27 |
| Timothy Rothwell | 24 |
| Jean Bizzari | 24 |
| Hans Bishop | 24 |
| Paul Blake | 23 |
| George Tidmarsh | 22 |
| Robert Hoffman | 22 |
| Susan Kelley | 22 |
| Andreas Fibig | 21 |
| Russell Ellison | 20 |
| Kevin Tang | 18 |
| Henry Ji | 17 |
| Craig Johnson | 17 |
- Bourse
- Insiders
- Robert H. Rosen
- Connexions Sociétés
